Table 2 Eligible studies and its characteristics
Author | Title | Year | Country | Study design |
|---|---|---|---|---|
Andrilla et al. | Prescribing practices of nurse practitioners and physician assistants waivered to prescribe buprenorphine and the barriers they experience prescribing buprenorphine | 2020 | USA | Survey design |
Andrilla et al. | Geographic distribution of providers with a DEA Waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5‐year update | 2019 | USA | Secondary data analysis |
Andrilla et al. | Projected contributions of nurse practitioners and physician’s assistant to buprenorphine treatment services for opioid use disorder in rural areas | 2020 | USA | Secondary data analysis |
Auty et al. | Buprenorphine waiver uptake among nurse practitioners and physician assistants: the role of existing waivered prescriber supply | 2020 | USA | Secondary data analysis and survey design |
Barnett et al. | In Rural areas, Buprenorphine Waiver adoption since 2017 driven by nurse practitioners and physician assistants | 2019 | USA | Secondary data analysis |
Bateman et al. | Psychopharmacological treatment of young people with substance dependence: a survey of prescribing practices in England | 2014 | England | Survey design |
Bates et al. | Facilitators and barriers to nurse practitioners prescribing methadone for opioid use disorder in nova scotia: a qualitative study | 2021 | Canada | Qualitative study design |
Carroll | Implementation of office-based buprenorphine treatment for opioid use disorder | 2021 | USA | One-group post-test-only design |
Comiskey et al. | Clients’ views on the importance of a nurse-led approach and nurse prescribing in the development of the healthy addiction treatment recovery model | 2019 | Ireland | A cross-sectional survey |
Dieujuste et al. | Provider perceptions of opioid safety measures in VHA emergency departments and urgent care centers | 2021 | USA | Survey design |
Domino et al. | Nudging primary care providers to expand the opioid use disorder workforce | 2021 | USA | Experimental design |
Elliott et al. | Changing nurse practitioner students' attitudes and beliefs about caring for those with opioid use disorders | 2021 | USA | Quasi-experimental design |
Jones et al. | Empowering psychiatric mental health nurse practitioners to expand treatment opportunities for veterans with opioid use disorder | 2020 | USA | Survey design |
Kameg et al. | Technology based educational approaches to address opioid use management by advanced practice registered nurses | 2020 | USA | Mixed methods survey design |
Klein et al. | The geographic impact of buprenorphine expansion to nurse practitioner prescribers in Oregon | 2020 | USA | Secondary data analysis |
Nguyen et al. | The association between scope of practice regulations and nurse practitioner prescribing of buprenorphine after the 2016 opioid bill | 2021 | USA | Secondary data analysis |
Roehler et al. | Buprenorphine prescription dispensing rates and characteristics following federal changes in prescribing policy, 2017–2018: a cross-sectional study | 2020 | USA | Secondary data analysis |
Saunders et al. | Medicaid participation among practitioners authorized to prescribe buprenorphine | 2021 | USA | Secondary Data Analysis |
Sorrell et al. | From policy to practice: pilot program increases access to medication for opioid use disorder in rural Colorado | 2020 | USA | Non-randomized intervention |
Spetz et al. | Barriers and facilitators of advanced practice registered nurse participation in medication treatment for opioid use disorder: a mixed methods study | 2021 | USA | Mixed methods |
Spetz et al. | Nurse practitioner and physician assistant waivers to prescribe buprenorphine and state scope of practice restrictions | 2019 | USA | Secondary data analysis |
Wakeman et al. | A hospital-wide initiative to redesign substance use disorder care: Impact on pharmacotherapy initiation | 2021 | USA | Secondary data analysis |